Suppr超能文献

对于接受减瘤手术及腹腔热灌注化疗治疗腹膜癌病的患者,术后C反应蛋白动力学可预测术后并发症。

Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

作者信息

Asmar Antoine El, Bendavides Melissa, Moreau Michel, Hendlisz Alain, Deleporte Amélie, Khalife Maher, Donckier Vincent, Liberale Gabriel

机构信息

Department of Surgical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, 121, Blvd. de Waterloo, 1000, Brussels, Belgium.

Department of Statistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

出版信息

World J Surg Oncol. 2020 Nov 26;18(1):311. doi: 10.1186/s12957-020-02081-6.

Abstract

BACKGROUND

Relatively high morbidity rates are reported after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). However, early predictors of complications after CRS plus HIPEC have not been identified. The aim of this study was to evaluate the predictive role of early postoperative serum C-reactive protein (CRP) level (Day 2-4) for the detection of post-operative complications.

PATIENTS AND METHODS

We performed a retrospective study including 94 patients treated with complete CRS (R1) and HIPEC for PC from various primary origins (2011-2016). Post-operative complications were recorded. The values for postoperative inflammatory markers (white blood cells [WBC] and platelet counts, CRP) were compared between the different groups.

RESULTS

CRP on post-operative days 2-4 was significantly higher in patients with than without complications (124 mg/L vs 46 mg/L; p < 0.0001) and higher in those with more major complications (162 mg/L vs 80 mg/L; p < 0.0012). WBC and platelet counts showed no difference within 5 days postoperatively.

CONCLUSION

CRP levels, and kinetics mainly, between post-operative day 2 and 4, are decisive predictive markers of early and late post-operative complications after CRS plus HIPEC. The presence of post-operative complications should be suspected in patients with a high CRP mean, and a plateau level (days 2-4).

摘要

背景

细胞减灭术(CRS)联合腹腔热灌注化疗(HIPEC)后报告的发病率相对较高。然而,CRS联合HIPEC术后并发症的早期预测指标尚未明确。本研究的目的是评估术后早期血清C反应蛋白(CRP)水平(第2 - 4天)对术后并发症检测的预测作用。

患者与方法

我们进行了一项回顾性研究,纳入了94例2011 - 2016年因各种原发灶接受根治性CRS(R1)和HIPEC治疗的PC患者。记录术后并发症情况。比较不同组之间术后炎症标志物(白细胞[WBC]、血小板计数、CRP)的值。

结果

有并发症的患者术后第2 - 4天的CRP显著高于无并发症的患者(124 mg/L对46 mg/L;p < 0.0001),且并发症更严重的患者CRP更高(162 mg/L对80 mg/L;p < 0.0012)。术后5天内WBC和血小板计数无差异。

结论

术后第2天至第4天的CRP水平及其动态变化主要是CRS联合HIPEC术后早期和晚期并发症的决定性预测标志物。CRP均值高且呈平台期水平(第2 - 4天)的患者应怀疑存在术后并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3866/7694318/f19fa90fb599/12957_2020_2081_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验